Unlock your next
breakthrough

Trusted by Industry Leaders at

Most software tools are just graphical interfaces to the same R packages. TerraFlow is the first platform built specifically for disease immunophenotyping.

Analysis

Complete cellular profiling

Ever wonder what you’re missing in your
data? Our exhaustive approach detects cell types routinely ignored by traditional methods, allowing scientists to extract new insights from the data they already have.

Annotation

Crystal clear phenotypes

Tired of staring at a UMAP plot all day? TerraFlow defines each cell type with an explicit gating strategy that can be directly sorted or developed as a clinical biomarker.

Access

On demand answers

Upload FCS files, label the patient groups you want to compare, and hit “Submit”. In 24 hours you’ll get back a complete immunophenotyping report.
It’s that easy.

Still clustering your data?

You may be leaving your biggest breakthroughs on the table

See how TerraFlow compares to traditional methods like FlowSOM and UMAP

UMAPFlowSOMTerraFlow
Phenotypes evaluatedNoneTensTens of thousands
Cell annotationVisual inspectionCluster MFIsExplicit gating strategies
TuningTune multiple parametersAnticipate number of clustersNo tuning necessary
RandomnessDifferent results every timeDifferent results every timeSame results every time
Use caseVisualize dataIdentify major subtypesDefine disease-associated cell types

Phenotypes evaluated

UMAPNone
FlowSOMTens
TerraFlowTens of thousands

Cell annotation

UMAPVisual inspection
FlowSOMCluster MFIs
TerraFlowExplicit gating strategies

Tuning

UMAPTune multiple parameters
FlowSOMAnticipate number of clusters
TerraFlowNo tuning necessary

Randomness

UMAPDifferent results every time
FlowSOMDifferent results every time
TerraFlowSame results every time

Use case

UMAPVisualize data
FlowSOMIdentify major subtypes
TerraFlowDefine disease-associated cell types

Our Promise

TerraFlow is the first platform built for disease immunophenotyping. If there’s a disease signature in your data, our platform will find it and deliver clear, replicable, disease-specific phenotypes every time.

Dan Freeman

Chief Executive Officer, TerraFlow